KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2018 - 2025)

Vertex Pharmaceuticals (VRTX) has 10 years of Interest Coverage Ratio data on record, last reported at 365.42 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio changed 0.27% year-over-year to 365.42; the TTM value through Dec 2025 reached 313.78, up 4222.68%, while the annual FY2025 figure was 313.78, 4222.68% up from the prior year.
  • Interest Coverage Ratio reached 365.42 in Q4 2025 per VRTX's latest filing, up from 359.45 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 366.43 in Q4 2024 and bottomed at 355.02 in Q2 2024.
  • Average Interest Coverage Ratio over 3 years is 170.07, with a median of 179.44 recorded in 2024.
  • The widest YoY moves for Interest Coverage Ratio: up 292.93% in 2024, down 487.4% in 2024.
  • A 3-year view of Interest Coverage Ratio shows it stood at 93.25 in 2023, then skyrocketed by 292.93% to 366.43 in 2024, then fell by 0.27% to 365.42 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 365.42 in Q4 2025, 359.45 in Q3 2025, and 311.11 in Q2 2025.